PrEP over time: does it change risky behavior?

NCT ID NCT06600087

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study in France looked at 248 people taking PrEP (a daily pill to prevent HIV) to see how their sexual behaviors and rates of other sexually transmitted infections (STIs) changed over time. Researchers compared those on PrEP for over a year to those on it for less than a year. The goal was to gather information to improve future prevention efforts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand how PrEP affects sexual behavior and STI rates over time, leading to improved prevention strategies.
What could go wrong: This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to other populations or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS SEXUALLY TRANSMITTED DISEASES

Contacts and locations

Locations

CHU de Bordeaux - Service de médecine interne et maladies infectieuses

Bordeaux, France
Cabinet de Medecine Generale

Fargues-Saint-Hilaire, France
Cabinet de Medecine Generale

Le Teich, France
Cabinet de Medecine Generale

Mérignac, France
Cegidd de Bordeaux

Bordeaux, France
Cegidd de Libourne

Libourne, France
Cegidd de Perigueux

Périgueux, France
Maison de la Santé de l'Hôpital Saint-André - Médecine Générale

Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.